Salto Partners

  • Home
  • About
  • Services
    • Strategy
    • Execution
    • Compliance
  • Verticals
    • Life Sciences
    • Genomics
    • Private Equity
  • Insights
    • ISO 13485
    • IVDR
    • Perspectives
      • National Genome Programs
      • Pharmacogenomics at Scale
      • Long-Read Sequencing
      • AI in Clinical Genomics
  • News
  • Contact

Life Sciences

We help diagnostics, medical device and biotech companies bring products to market with the right channels, partners and quality systems.

What makes life sciences different

Life sciences markets reward evidence, not hype. Customers are scientists, clinicians, lab directors and procurement teams, and they buy only when the data convinces them. Sales cycles are long, decisions involve many stakeholders, and adoption often depends on publications, key opinion leaders and reimbursement. Markets are specialized and global, so even a small company needs an international reach early.

At the same time, every claim you make is regulated. What you can say in a brochure, on a website or in a sales meeting depends on how your product is cleared or certified. Commercial and regulatory strategy cannot be separated.

What commercial success really means

Revenue alone is not the measure. Commercial success in life sciences means repeatable adoption that scales:

  • A clearly defined target customer and a value proposition backed by data
  • Reference customers, publications and advocates who sell for you
  • Recurring revenue from consumables, software subscriptions or test volume
  • A predictable pipeline and a forecast leadership can trust
  • The right mix of direct sales, distributors and partners in each region
  • Healthy margins and a cost of sale that falls as you grow

Understanding the regulatory hurdles

Regulation shapes which markets you can enter, which claims you can make and how fast you can move. In Europe, the In Vitro Diagnostic Regulation (IVDR) and Medical Device Regulation (MDR) have raised the bar for technical documentation, clinical evidence and notified body review. In the U.S., FDA pathways and evolving oversight of laboratory tests set the timeline. Underneath it all, an ISO 13485 quality management system is the foundation.

We help you build a regulatory strategy that supports the commercial plan: which products and claims to pursue first, which markets to sequence, how research-use and clinical products are positioned, and how to keep distributors and partners compliant.

Marketing and sales, AI-enabled

Life sciences marketing and sales is a precision game. We help you build a focused, modern commercial engine:

  • Account-based marketing to defined segments of labs, hospitals and research centers
  • Scientific content, webinars and KOL programs that build credibility
  • Inside sales, field sales and application specialists working as one team
  • AI to identify and prioritize accounts, personalize outreach and summarize calls
  • AI-assisted forecasting, proposal and tender drafting, and CRM hygiene
  • Clear guardrails, so AI-generated content stays accurate and within approved claims

Ready to talk? Send us an email and we will set up a conversation.

© 2026 Salto Partners Inc. ยท Strategy. Execution. Compliance.